Concepedia
Statistics
Publications
237
Citations
15.2K
H-Index
64
Active since
1961
Affiliations
University of Minnesota(Current)
Institute of Medicinal Plant Development
Twin Cities Orthopedics
University of Minnesota Medical Center
Philip S. Portoghese is an author at University of Minnesota specializing in medicine, pharmacology, and neuropharmacology.
Top concepts
PharmacologyMedicinePharmacotherapyNeuropharmacologyMolecular PharmacologyDrug DiscoveryBiochemistryOpioid Use DisorderMedicinal ChemistryHealth
Publications per year
1961–2019
Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist
Philip S. Portoghese, Marjia Sultana, A.E. Takemori · European Journal of Pharmacology · 1988 · 613 citations
Molecular Pharmacology, Drug Discovery, Pharmacology +7
Binaltorphimine and nor-binaltorphimine, potent and selective k-opioid receptor antagonists
Philip S. Portoghese, A. W. Lipkowski, A.E. Takemori · Life Sciences · 1987 · 532 citations
Functional Selectivity, Medicine, Opioid Use Disorder +4
Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in the Forced Swim Test in Rats
Stephen D. Mague, Andrea M. Pliakas, Mark S. Todtenkopf et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 478 citations
Selective blockage of delta opioid receptors prevents the development of morphine tolerance and dependence in mice.
Essam E. Abdelhamid, Marjia Sultana, Philip S. Portoghese et al. · Journal of Pharmacology and Experimental Therapeutics · 1991 · 426 citations
Nor-binaltorphimine, a highly selective kappa-opioid antagonist in analgesic and receptor binding assays.
A.E. Takemori, Begonia Y. Ho, J S Naeseth et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 411 citations
1–5 of 237